Showing results (1711-1720 of 16,597) with videos related to
Sort By:
Pageof 1,660
Cancer Letters|December 22, 2016
LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2Dong Liu, Yawei Li, Gang Luo, et al.Cancer Letters|December 22, 2016
Rocaglamide breaks TRAIL-resistance in human multiple myeloma and acute T-cell leukemia in vivo in a mouse xenogtraft modelYin Wu, Marco Giaisi, Rebecca Köhler, et al.Cancer Letters|December 24, 2016
Inflammatory landscape of human brain tumors reveals an NFκB dependent cytokine pathway associated with mesenchymal glioblastomaAlfeu Zanotto-Filho, Rosângela Mayer Gonçalves, Karina Klafke, et al.Cancer Letters|December 27, 2016
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohortsPaola Todeschini, Elisa Salviato, Lara Paracchini, et al.Cancer Letters|December 17, 2016
Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1João Ramalho-Carvalho, João Barbosa Martins, Lina Cekaite, et al.Cancer Letters|December 15, 2016
Trichodermin induces c-Jun N-terminal kinase-dependent apoptosis caused by mitotic arrest and DNA damage in human p53-mutated pancreatic cancer cells and xenograftsMing-Hsien Chien, Tzong-Huei Lee, Wei-Jiunn Lee, et al.Cancer Letters|January 30, 2008
Incidentally simultaneous occurrence of RET/PTC, H4-PTEN and BRAF mutation in papillary thyroid carcinomaYu-Long Wang, Jiu-Cun Wang, Yi Wu, et al.Cancer Letters|February 1, 2008
Protein tyrosine phosphatase inhibition induces anti-tumor activity: evidence of Cdk2/p27 kip1 and Cdk2/SHP-1 complex formation in human ovarian cancer cellsDanielle Caron, Pierre E Savard, Charles J Doillon, et al.Cancer Letters|February 5, 2008
Immunotherapy prolongs the serum CEA-TPA-CA15.3 lead time at the metastatic progression in endocrine-dependent breast cancer patients: a retrospective longitudinal studyA Nicolini, A Carpi, P Ferrari, et al.Cancer Letters|December 15, 2007
Vitamin D receptor polymorphisms and risk of epithelial ovarian cancerTess V Clendenen, Alan A Arslan, Karen L Koenig, et al.Pageof 1,660